GlassScriptPhysician profile
Megan Mase
NPI 1912387267
$5,800.34
in general payments reported to CMS, 2019-2025
32 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $326 · 2021: $174 · 2022: $432 · 2023: $1,180 · 2024: $1,660 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,269.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,086.95 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $785.61 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $632.40 | 2023-2025 | |
| Glaxosmithkline, LLC. | $502.40 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $498.66 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $433.27 | 2019-2025 | |
| Lilly USA, LLC | $322.42 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.01 | 2019-2024 | Jardiance, Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $156.05 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $155.97 | 2024-2025 | Fanapt |
| Bayer Healthcare Pharmaceuticals INC. | $154.16 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $124.52 | 2023-2025 | Gvoke Hypopen |
| Amgen INC. | $109.50 | 2022-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $92.43 | 2019-2023 | Xarelto |
| Exact Sciences Corporation | $82.49 | 2023-2025 | Cologuard Collection Kit |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $58.96 | 2019-2023 | |
| Genentech USA, INC. | $50.23 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $45.52 | 2019-2020 | |
| Vbi Vaccine (Delaware) INC. | $38.85 | 2022 | |
| Dexcom, INC. | $37.03 | 2023-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $35.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.76 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $32.04 | 2023 | Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.70 | 2019-2020 | |
| Astellas Pharma US INC | $21.51 | 2024 | Veozah |
| Philips North America LLC | $18.76 | 2024 | (Ck7) Extended Holter |
| Seqirus USA INC | $17.90 | 2025 | Fluad, Flucelvax |
| Alkermes, INC. | $17.53 | 2022 | |
| Nevro Corp. | $16.87 | 2023 | Senza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.59 | 2025 | Caplyta |
| Alexion Pharmaceuticals, INC. | $12.30 | 2022 | |
| Allergan, INC. | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.